Jane Y. Edwards

2.1k total citations
33 papers, 1.8k citations indexed

About

Jane Y. Edwards is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Jane Y. Edwards has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Jane Y. Edwards's work include Cholesterol and Lipid Metabolism (16 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). Jane Y. Edwards is often cited by papers focused on Cholesterol and Lipid Metabolism (16 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). Jane Y. Edwards collaborates with scholars based in Canada, Australia and United States. Jane Y. Edwards's co-authors include Murray W. Huff, Cynthia G. Sawyez, Dawn E. Telford, Brian G. Sutherland, Robert A. Hegele, Emma M. Allister, Erin E. Mulvihill, Nica M. Borradaile, Amy C. Burke and Carmen Argmann and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Diabetes.

In The Last Decade

Jane Y. Edwards

33 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Y. Edwards Canada	21	760	627	386	366	318	33	1.8k
Dawn E. Telford Canada	27	792 1.0×	876 1.4×	413 1.1×	548 1.5×	365 1.1×	45	2.1k
Cynthia G. Sawyez Canada	26	938 1.2×	661 1.1×	498 1.3×	473 1.3×	389 1.2×	44	2.2k
Brian G. Sutherland Canada	17	559 0.7×	318 0.5×	352 0.9×	324 0.9×	378 1.2×	35	1.4k
Makoto Ayaori Japan	26	547 0.7×	744 1.2×	241 0.6×	432 1.2×	392 1.2×	83	2.2k
Lídia Cedó Spain	26	631 0.8×	389 0.6×	201 0.5×	231 0.6×	163 0.5×	50	1.5k
Susanne Zadelaar Netherlands	8	577 0.8×	402 0.6×	359 0.9×	175 0.5×	158 0.5×	9	1.7k
Josefa Girona Spain	31	1.1k 1.5×	541 0.9×	500 1.3×	472 1.3×	216 0.7×	108	2.5k
Yujing Xia China	31	947 1.2×	364 0.6×	755 2.0×	168 0.5×	100 0.3×	59	2.4k
Emma M. Allister Canada	18	849 1.1×	755 1.2×	302 0.8×	455 1.2×	208 0.7×	25	1.9k
Khadija Ouguerram France	26	555 0.7×	966 1.5×	324 0.8×	641 1.8×	92 0.3×	101	2.1k

Countries citing papers authored by Jane Y. Edwards

Since Specialization

Citations

This map shows the geographic impact of Jane Y. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Y. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Y. Edwards more than expected).

Fields of papers citing papers by Jane Y. Edwards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Y. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Y. Edwards. The network helps show where Jane Y. Edwards may publish in the future.

Co-authorship network of co-authors of Jane Y. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Y. Edwards. A scholar is included among the top collaborators of Jane Y. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Y. Edwards. Jane Y. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burke, Amy C., Brian G. Sutherland, Dawn E. Telford, et al.. (2019). Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr mice. Atherosclerosis. 286. 60–70. 26 indexed citations

Burke, Amy C., Brian G. Sutherland, Dawn E. Telford, et al.. (2018). Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice. Journal of Lipid Research. 59(9). 1714–1728. 99 indexed citations

Burke, Amy C., Dawn E. Telford, Jane Y. Edwards, et al.. (2018). Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Ldlr-/- Mice with Isocaloric Food Intake. Atherosclerosis Supplements. 32. 23–23. 1 indexed citations

Burke, Amy C., Dawn E. Telford, Jane Y. Edwards, et al.. (2018). Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair‐Fed Ldlr^−/− Mice. Molecular Nutrition & Food Research. 63(6). e1800833–e1800833. 33 indexed citations

Burke, Amy C., Dawn E. Telford, Brian G. Sutherland, et al.. (2016). Abstract 18: Bempedoic Acid Lowers Low Density Lipoprotein-Cholesterol and Attenuates Aortic Atherosclerosis in LDL Receptor-Deficient ( LDLR ^+/- and LDLR ^-/- ) Yucatan Miniature Pigs. Arteriosclerosis Thrombosis and Vascular Biology. 36(suppl_1). 1 indexed citations

Telford, Dawn E., Morgan D. Fullerton, Rebecca J. Ford, et al.. (2014). PPARδ activation attenuates hepatic steatosis in Ldlr mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity. Journal of Lipid Research. 55(7). 1254–1266. 67 indexed citations

Burke, Amy C., Dawn E. Telford, Brian G. Sutherland, et al.. (2013). Peroxisome Proliferator–Activated Receptor δ Agonist GW1516 Attenuates Diet-Induced Aortic Inflammation, Insulin Resistance, and Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(1). 52–60. 45 indexed citations

Assini, Julia M., Erin E. Mulvihill, Brian G. Sutherland, et al.. (2012). Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice. Journal of Lipid Research. 54(3). 711–724. 113 indexed citations

Sawyez, Cynthia G., et al.. (2012). Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Human Macrophage Foam Cell Formation and the Inflammatory Response Induced by Very Low-Density Lipoprotein. Arteriosclerosis Thrombosis and Vascular Biology. 32(12). 2919–2928. 45 indexed citations

10.

Mulvihill, Erin E., Emma M. Allister, Brian G. Sutherland, et al.. (2009). Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance. Diabetes. 58(10). 2198–2210. 250 indexed citations

11.

Allister, Emma M., et al.. (2008). Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor. Journal of Lipid Research. 49(10). 2218–2229. 43 indexed citations

12.

Wang, Jian, John F. Robinson, Caroline O’Neil, et al.. (2006). Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles. Journal of Human Genetics. 51(11). 934–942. 14 indexed citations

13.

Telford, Dawn E., Brian G. Sutherland, Jane Y. Edwards, et al.. (2006). The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. Journal of Lipid Research. 48(3). 699–708. 91 indexed citations

14.

Beyea, Michael M., Claire Heslop, Cynthia G. Sawyez, et al.. (2006). Selective Up-regulation of LXR-regulated Genes ABCA1, ABCG1, and APOE in Macrophages through Increased Endogenous Synthesis of 24(S),25-Epoxycholesterol. Journal of Biological Chemistry. 282(8). 5207–5216. 85 indexed citations

15.

Argmann, Carmen, Jane Y. Edwards, Cynthia G. Sawyez, et al.. (2005). Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition. Journal of Biological Chemistry. 280(23). 22212–22221. 107 indexed citations

16.

Telford, Dawn E., P. Hugh R. Barrett, Brian G. Sutherland, et al.. (2005). A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low–Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content. Arteriosclerosis Thrombosis and Vascular Biology. 25(12). 2608–2614. 20 indexed citations

17.

Telford, Dawn E., Jane Y. Edwards, Brian G. Sutherland, et al.. (2003). Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB. Journal of Lipid Research. 44(5). 943–952. 20 indexed citations

18.

Huff, Murray W., Dawn E. Telford, Jane Y. Edwards, et al.. (2002). Inhibition of the Apical Sodium-Dependent Bile Acid Transporter Reduces LDL Cholesterol and ApoB by Enhanced Plasma Clearance of LDL ApoB. Arteriosclerosis Thrombosis and Vascular Biology. 22(11). 1884–1891. 51 indexed citations

19.

Denomme, Gregory A., et al.. (1995). The role of the immunoglobulin heavy chain in human anti‐dna antibody binding specificity. Arthritis & Rheumatism. 38(3). 389–395. 9 indexed citations

20.

Denomme, Gregory A., Mahmoud Mahmoudi, Jane Y. Edwards, et al.. (1993). Immunoglobulin V region heavy and light chain gene sequences of the lymphoblastoid cell line GM 4672. Human Antibodies. 4(3). 98–103. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact